Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Multiple Pulmonary Nodules 1Lung Neoplasms 1Liver Neoplasms 1Hemorrhage 1Blood Loss, Surgical 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neuromuscular Blockade × 1 year × Clear all
NCT07395375 2026-02-09

NIVA-TSLR

The First Affiliated Hospital of Guangzhou Medical University

Phase NA Not yet recruiting
1,600 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

NCT04609410 2025-08-07

MODELS

Università Vita-Salute San Raffaele

Phase NA Terminated
48 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon âš¡